| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 424780050 | Anti-inflammatory or anti-irritant (e.g., anti-arthritic, etc.) | 12 |
| 20080247986 | Hyaluronidase Inhibitor Containing Poly-Gamma-Glutamic Acid as an Effective Component - The present invention relates to a hyaluronidase inhibitor containing poly-gamma-glutamic acid (PGA) as an active ingredient, a composition for maintaining skin elasticity and a composition for improving allergy, wherein each of the compositions contains PGA as an active ingredient. The inventive compositions containing PGA are effective in maintaining skin moisturization and skin elasticity by effectively inhibiting the activity of hyaluronidase which is an enzyme that degrades hyaluronic acid present in the skin dermis. Also, the compositions can relieve allergic symptoms by inhibiting the permeability of inflammatory cells. | 10-09-2008 |
| 20080260677 | Transdermal Topical Composition and Its Uses - An emollient component is provided in a composition, suitable for topical application to skin, comprising a fugitive solvent base comprising at least one alcohol. One advantage of the invention is that the irritancy potential of the composition due to the alcoholic fugitive solvent base is reduced. | 10-23-2008 |
| 20090148394 | TREATMENT OF CHRONIC ULCEROUS SKIN LESIONS - The invention provides a method of treating a wound (for example, a chronic ulcerous skin lesion) in a human or non-human mammal (particularly a human). The wound is contacted with a topical hydrogel composition comprising a hydrophilic polymer carrying multiple pendant sulphonyl groups, optionally with multiple pendant carboxylic groups, on each polymer molecule. | 06-11-2009 |
| 20100003210 | EXTERNAL SKIN AGENT COMPRISING MODIFIED CLAY FOR PREVENTING INFLAMMATION - To provide An external skin agent that prevents onset of atopic skin inflammations and is low irritant to skin, which is characterized by including: 1) clay modified by a compound having a quaternary amino group; and 2) a polymer or copolymer that has a side chain including a structure similar to a biological component. | 01-07-2010 |
| 20100143285 | Dermatological/pharmaceutical compositions comprising benzoyl peroxide, at least one naphthoic acid compound and at least one polyurethane polymer - Topically applicable, dermatological/pharmaceutical compositions contain, formulated into a physiologically acceptable medium, benzoyl peroxide, at least one naphthoic acid compound and at least one compound of the polyurethane polymer type or derivatives thereof, wherein the benzoyl peroxide and the at least one naphthoic acid compound are dispersed therein. | 06-10-2010 |
| 20120237471 | Poly(CPP-SA) Anhydride As A Reactive Barrier Matrix Against Percutaneous Absorption Of Toxic Chemicals - The present invention relates to a protective agent suitable to protect the human skin against toxic materials, particularly against chemicals with nucleophilic sites. The active moiety is a polyanhydride derivative. The active transdermal retardant offers a barrier property and chemically and/or physically reacts with harmful chemicals to decrease percutaneous absorption. In the preferred embodiments, polyanhydride in its low molecular weight form reduced flux of nicotine and nitrofurazone significantly. Additionally, polyanhydride in its high molecular weight form prevented nicotine absorption and decreased nitrofurazone permeation dramatically. Moreover, the polyanhydride in its high molecular weight form reduced nitroglycerin flux to a lesser extent. | 09-20-2012 |
| 20130078209 | COMPOSITIONS AND METHODS FOR TREATING CONDITIONS OF COMPROMISED SKIN BARRIER FUNCTION - Compositions and methods of treating conditions of compromised skin barrier function are described. | 03-28-2013 |
| 20130287724 | ANTI-ADHERENT FORMULATION INCLUDING AN ANIONIC OR NONIONIC POLYMER - Liquid formulations having anti-adherent properties are disclosed herein. The liquid anti-adherent formulation described herein acts to prevent the adherence of menses and/or fecal material to the skin in the labial and perianal regions during and after menstruation or defecation, respectively. The liquid anti-adherent formulation contains a carrier, a polymer selected from an anionic polymer, nonionic polymer, and combinations thereof. Anti-adherent formulation was found to be effective if a menses leave-on percentage as defined within the Menses Leave-On Percentage Test method described herein of less than 7.2% after two insults. | 10-31-2013 |
| 20140044667 | HEALING COMPOSITION FOR TOPICAL APPLICATION - The present invention relates to a hygiene product or a pharmaceutical composition in the form of a gel or dressing, for topical application to the skin or mucosa including glycerol, at least one poly(meth)acrylate polymer, at least one polyethylene glycol having a molecular weight of less than 1000 g/mol, octanediol and water. | 02-13-2014 |
| 20150297785 | Wound Healing Material And Application Thereof - The present invention provides a wound healing material and its application thereof. The wound healing material comprises a hydrophobic fluoro-containing membrane having a first surface and a second surface opposing to each other; and at least one biocompatible polymer covalently bonded to at least one part of the first surface of the membrane wherein the membrane is air permeable but liquid impermeable and the water contact angle of the first surface formed with the biocompatible polymer is smaller than or equal to 40 degrees. | 10-22-2015 |
| 20150352033 | ANTI-ADHERENT FORMULATION INCLUDING AN ANIONIC OR NONIONIC POLYMER - Liquid formulations having anti-adherent properties are disclosed herein. The liquid anti-adherent formulation described herein acts to prevent the adherence of menses and/or fecal material to the skin in the labial and perianal regions during and after menstruation or defecation, respectively. The liquid anti-adherent formulation contains a carrier, a polymer selected from an anionic polymer, nonionic polymer, and combinations thereof. Anti-adherent formulation was found to be effective if a menses leave-on percentage as defined within the Menses Leave-On Percentage Test method described herein of less than 7.2% after two insults. | 12-10-2015 |
| 20150359817 | METHOD OF TREATING INFLAMED, IRRITATED, AND SENSITIVE SKIN USING A POLYLMER SUSPENSION SYSTEM, METHOD FOR PREPARING THE SAME, AND PRODUCTS MADE THEREOF - One aspect of the present invention provides a use of polymer 2-(methacryloyloxy)ethyl-2-(trimethylammonio)ethyl phosphate-stearylmethacrylate copolymer suspension as a compound which is beneficial to inflamed, irritated and sensitive skin. According to an alternative further aspect of the present invention there is provided a method of preparing a fabric which is non-irritating to the skin, said method comprising: scouring a fabric; rinsing the scoured fabric; coating the fabric with a polymer suspension having dual hydrophilic and hydrophobic characteristics; and finally setting the coated fabric to the required dimensions using a heat drying process so that an original handfeel of the fabric is not affected by the coating. | 12-17-2015 |
